Valuation: Samsung Biologics Co.,Ltd.

Capitalization 76,24100Cr 5.15TCr 4.43TCr 4.03TCr 3.85TCr 7.03TCr 4,72200Cr 7.33TCr 47TCr 19TCr 2,26500Cr 19TCr 19TCr 8,12100Cr P/E ratio 2026 *
44.9x
P/E ratio 2027 * 35.6x
Enterprise value 7.31TCr 4.93Cr 4.25Cr 3.86Cr 3.69Cr 6.74Cr 452.66Cr 7.03Cr 45Cr 18Cr 217.17Cr 19Cr 18Cr 778.5Cr EV / Sales 2026 *
13.5x
EV / Sales 2027 * 10.3x
Free-Float
25.44%
Yield 2026 *
-
Yield 2027 * 0.03%
1 day+8.64%
1 week+64.70%
Current month+64.70%
1 month+64.70%
3 months+64.70%
6 months+64.70%
Current year+64.70%
1 week 10,00,000
Extreme 999999.9999
16,69,000
1 month 10,00,000
Extreme 999999.9999
16,69,000
Current year 10,00,000
Extreme 999999.9999
16,69,000
1 year 10,00,000
Extreme 999999.9999
16,69,000
3 years 10,00,000
Extreme 999999.9999
16,69,000
5 years 10,00,000
Extreme 999999.9999
16,69,000
10 years 1,92,960.76
Extreme 192960.7607
16,69,000
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Chairman 64 09/12/2020
Director/Board Member 72 29/03/2022
Director/Board Member 67 20/03/2020
Change 5d. change 1-year change 3-years change Capi.($)
+8.64%+64.70%+64.70%+64.70% 4.8TCr
-2.87%-0.76%+11.32%-1.98% 8.08TCr
-1.98%-4.38%+32.22%+222.78% 5.82TCr
+2.54%+0.95%-44.66%-50.01% 4.86TCr
-0.98%+0.03%+30.82%-30.41% 2.79TCr
-6.87%+4.10%+52.88%-62.63% 2.28TCr
-1.55%-2.76%+39.42%+28.32% 1.97TCr
+1.10%-11.26%+94.18%+85.68% 1.72TCr
-1.29%-5.78%+19.72%+57.33% 1.46TCr
+12.05%-7.46%-7.00%+908.13% 1.21TCr
Average +1.59%-2.38%+29.36%+122.19% 3.5TCr
Weighted average by Cap. +0.81%-1.79%+23.99%+71.75%

Financials

2026 *2027 *
Net sales 5,39600Cr 364.21Cr 313.49Cr 284.9Cr 272.49Cr 497.49Cr 33TCr 519.07Cr 3.36TCr 1.34TCr 16TCr 1.37TCr 1.34TCr 57TCr 6,99200Cr 471.98Cr 406.25Cr 369.19Cr 353.11Cr 644.69Cr 43TCr 672.66Cr 4.35TCr 1.74TCr 21TCr 1.77TCr 1.73TCr 74TCr
Net income 1,81500Cr 122.53Cr 105.47Cr 96Cr 92Cr 167.37Cr 11TCr 174.63Cr 1.13TCr 451.11Cr 5.39TCr 460Cr 450.02Cr 19TCr 2,24400Cr 151.48Cr 130.39Cr 118.49Cr 113.33Cr 206.91Cr 14TCr 215.89Cr 1.4TCr 557.68Cr 6.67TCr 568.67Cr 556.33Cr 24TCr
Net Debt -3,15600Cr -213Cr -183.34Cr -166.62Cr -159.36Cr -290.95Cr -20TCr -303.57Cr -1.96TCr -784.17Cr -9.38TCr -799.63Cr -782.28Cr -34TCr -3,88500Cr -262.21Cr -225.69Cr -205.1Cr -196.17Cr -358.15Cr -24TCr -373.69Cr -2.42TCr -965.3Cr -12TCr -984.34Cr -962.97Cr -41TCr
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
Date Price Change Volume
05/26/05 16,47,000.00 +8.64% 70,178
04/26/04 15,16,000.00 -9.82% 83,414
03/26/03 16,81,000.00 -5.46% 81,261
27/26/27 17,78,000.00 +0.68% 97,725
26/26/26 17,66,000.00 +2.20% 88,413
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
16,47,000.00KRW
Average target price
22,53,934.38KRW
Spread / Average Target
+36.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock